NO20003730D0 - Triazolo-pyridazinderivater som ligander for GABA reseptorer - Google Patents

Triazolo-pyridazinderivater som ligander for GABA reseptorer

Info

Publication number
NO20003730D0
NO20003730D0 NO20003730A NO20003730A NO20003730D0 NO 20003730 D0 NO20003730 D0 NO 20003730D0 NO 20003730 A NO20003730 A NO 20003730A NO 20003730 A NO20003730 A NO 20003730A NO 20003730 D0 NO20003730 D0 NO 20003730D0
Authority
NO
Norway
Prior art keywords
triazolo
ligands
pyridazine derivatives
gaba receptors
gaba
Prior art date
Application number
NO20003730A
Other languages
English (en)
Other versions
NO315516B1 (no
NO20003730L (no
Inventor
William Robert Carling
Jose Luis Castro Pineiro
Ian James Collins
Alexander Richard Guiblin
Timothy Harrison
Andrew Madin
Kevin William Moore
Michael Geoffrey Neil Russell
Gayle Scott
Leslie Joseph Street
Original Assignee
Merck Sharp & Dohne Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9801233.9A external-priority patent/GB9801233D0/en
Priority claimed from GBGB9821517.1A external-priority patent/GB9821517D0/en
Application filed by Merck Sharp & Dohne Ltd filed Critical Merck Sharp & Dohne Ltd
Publication of NO20003730D0 publication Critical patent/NO20003730D0/no
Publication of NO20003730L publication Critical patent/NO20003730L/no
Publication of NO315516B1 publication Critical patent/NO315516B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO20003730A 1998-01-21 2000-07-20 Triazolo-pyridazinderivater som ligander for GABA-reseptorer NO315516B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9801233.9A GB9801233D0 (en) 1998-01-21 1998-01-21 Therapeutic agents
GBGB9821517.1A GB9821517D0 (en) 1998-10-02 1998-10-02 Therapeutic agents
PCT/GB1999/000103 WO1999037644A1 (en) 1998-01-21 1999-01-13 Triazolo-pyridazine derivatives as ligands for gaba receptors

Publications (3)

Publication Number Publication Date
NO20003730D0 true NO20003730D0 (no) 2000-07-20
NO20003730L NO20003730L (no) 2000-09-20
NO315516B1 NO315516B1 (no) 2003-09-15

Family

ID=26312988

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20003730A NO315516B1 (no) 1998-01-21 2000-07-20 Triazolo-pyridazinderivater som ligander for GABA-reseptorer

Country Status (24)

Country Link
US (2) US6579875B1 (no)
EP (1) EP1049696A1 (no)
JP (1) JP2002501066A (no)
KR (1) KR20010034257A (no)
CN (1) CN1110498C (no)
AU (1) AU748737B2 (no)
BG (1) BG104671A (no)
BR (1) BR9906905A (no)
CA (1) CA2315763A1 (no)
CZ (1) CZ290883B6 (no)
EA (1) EA002755B1 (no)
EE (1) EE200000430A (no)
GE (1) GEP20032868B (no)
HR (1) HRP20000492A2 (no)
HU (1) HUP0100575A3 (no)
IL (1) IL136442A0 (no)
IS (1) IS5540A (no)
MX (1) MXPA00007135A (no)
NO (1) NO315516B1 (no)
NZ (1) NZ504870A (no)
PL (1) PL341652A1 (no)
SK (1) SK10922000A3 (no)
WO (1) WO1999037644A1 (no)
YU (1) YU43800A (no)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
YU43800A (sh) * 1998-01-21 2002-12-10 Merck Sharp & Dohme Limited Triazolo-piridazin derivati kao ligandi za gaba receptore
GB9929685D0 (en) 1999-12-15 2000-02-09 Merck Sharp & Dohme Therapeutic agents
GB0017543D0 (en) * 2000-07-17 2000-09-06 Merck Sharp & Dohme Therapeutic agents
JP4867350B2 (ja) * 2003-12-19 2012-02-01 宇部興産株式会社 ４−置換−４−シアノテトラヒドロピラン化合物の製法
EP2258358A3 (en) 2005-08-26 2011-09-07 Braincells, Inc. Neurogenesis with acetylcholinesterase inhibitor
EP1928437A2 (en) 2005-08-26 2008-06-11 Braincells, Inc. Neurogenesis by muscarinic receptor modulation
EP1940389A2 (en) 2005-10-21 2008-07-09 Braincells, Inc. Modulation of neurogenesis by pde inhibition
US20070112017A1 (en) * 2005-10-31 2007-05-17 Braincells, Inc. Gaba receptor mediated modulation of neurogenesis
HUE030390T2 (en) * 2005-12-21 2017-05-29 Janssen Pharmaceutica Nv Triazolopyridazines as tyrosine kinase modulators
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
WO2007134077A2 (en) 2006-05-09 2007-11-22 Braincells, Inc. 5 ht receptor mediated neurogenesis
AU2007249399A1 (en) 2006-05-09 2007-11-22 Braincells, Inc. Neurogenesis by modulating angiotensin
EP2068872A1 (en) 2006-09-08 2009-06-17 Braincells, Inc. Combinations containing a 4-acylaminopyridine derivative
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
EP2123619A1 (de) 2008-05-20 2009-11-25 Bayer Schering Pharma AG Neue [F-18]-Markierte L-Glutaminsäure-und L-Glutaminderivate (II), ihre Verwendung sowie Verfahren zu ihrer Herstellung
CA2735549A1 (en) * 2008-08-29 2010-03-04 Concert Pharmaceuticals, Inc. Substituted triazolo-pyridazine derivatives
WO2010099217A1 (en) 2009-02-25 2010-09-02 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations
US8501738B2 (en) 2009-06-23 2013-08-06 Concert Pharmaceuticals, Inc. Substituted triazolo-pyridazine derivatives
US8952034B2 (en) * 2009-07-27 2015-02-10 Gilead Sciences, Inc. Fused heterocyclic compounds as ion channel modulators
WO2012050907A2 (en) 2010-09-28 2012-04-19 The Regents Of The University Of California Gaba agonists in the treatment of disorders associated with metabolic syndrome and gaba combinations in treatment or prophylaxis of type i diabetes
CA2834164A1 (en) 2011-05-10 2012-11-15 Gilead Sciences, Inc. Fused benzoxazinones as ion channel modulators
TW201837023A (zh) 2011-07-01 2018-10-16 美商基利科學股份有限公司 作為離子通道調節劑之稠合雜環化合物
NO3175985T3 (no) 2011-07-01 2018-04-28
GB201321745D0 (en) * 2013-12-09 2014-01-22 Ucb Pharma Sa Therapeutic agents
JP7105696B2 (ja) 2016-02-29 2022-07-25 デイナ ファーバー キャンサー インスティチュート，インコーポレイテッド 感染症を治療するステープル化細胞内ターゲティング抗微生物ペプチド
CN107344936B (zh) * 2016-05-06 2022-06-03 上海赛默罗生物科技有限公司 三唑哒嗪类衍生物、其制备方法、药物组合物和用途
JP7305614B2 (ja) 2017-07-19 2023-07-10 デイナ ファーバー キャンサー インスティチュート，インコーポレイテッド 抗生物質耐性細菌感染症の処置のための安定化抗菌ペプチド

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4230705A (en) * 1976-09-22 1980-10-28 American Cyanamid Company 6-Phenyl-1,2,4-triazolo[4,3-b]pyridazines and their uses in treating anxiety
CA1080712A (en) 1976-09-22 1980-07-01 Jay D. Albright Hypotensive agents
US4112095A (en) 1976-10-07 1978-09-05 American Cyanamid Company 6-Phenyl-1,2,4-triazolo[4,3-b]pyridazine hypotensive agents
PH12424A (en) * 1976-10-26 1979-02-15 American Cyanamid Co Method of treating anxiety in mammals
US4260755A (en) 1979-10-31 1981-04-07 American Cyanamid Company Novel 6-phenyl and substituted 6-phenyl-1,2,4-triazolo[4,3-b]pyridazines
US4260756A (en) * 1979-11-15 1981-04-07 American Cyanamid Company 6- And 8-heteroaryl-1,2,4-triazolo[4,3-b]pyridazines
FI81350C (fi) * 1982-01-18 1990-10-10 Lepetit Spa Analogfoerfarande foer framstaellning av nya, farmakologiskt aktiva 6-substituerade s-triatsolo/3,4-a/ ftalazinderivat.
IT1194310B (it) 1983-07-12 1988-09-14 Lepetit Spa Derivati triazolo (3,4-a) ftalazinici 3,6-disostituiti
US4654343A (en) * 1985-10-31 1987-03-31 American Cyanamid Company N-substituted-N[3-(1,2,4-triazolo[4,3-b]pyridazin-6-yl)phenyl]alkanamides, carbamates and ureas
ES2194205T3 (es) * 1996-07-25 2003-11-16 Merck Sharp & Dohme Derivados de triazolo-piridazina sustituidos como ligandos para los receptores gaba.
YU43800A (sh) * 1998-01-21 2002-12-10 Merck Sharp & Dohme Limited Triazolo-piridazin derivati kao ligandi za gaba receptore

Also Published As

Publication number Publication date
AU2065799A (en) 1999-08-09
IL136442A0 (en) 2001-06-14
NO315516B1 (no) 2003-09-15
SK10922000A3 (sk) 2001-03-12
YU43800A (sh) 2002-12-10
AU748737B2 (en) 2002-06-13
HUP0100575A3 (en) 2003-03-28
MXPA00007135A (es) 2002-11-07
KR20010034257A (ko) 2001-04-25
BG104671A (en) 2001-05-31
EA200000783A1 (ru) 2000-12-25
US20040063714A1 (en) 2004-04-01
NO20003730L (no) 2000-09-20
IS5540A (is) 2000-06-16
BR9906905A (pt) 2000-10-10
HUP0100575A2 (hu) 2001-09-28
CN1110498C (zh) 2003-06-04
EA002755B1 (ru) 2002-08-29
HRP20000492A2 (en) 2000-12-31
CA2315763A1 (en) 1999-07-29
PL341652A1 (en) 2001-04-23
EE200000430A (et) 2001-12-17
CZ290883B6 (cs) 2002-11-13
US6579875B1 (en) 2003-06-17
GEP20032868B (en) 2003-01-27
NZ504870A (en) 2002-11-26
EP1049696A1 (en) 2000-11-08
WO1999037644A1 (en) 1999-07-29
CZ20002691A3 (cs) 2000-12-13
JP2002501066A (ja) 2002-01-15
US6828322B2 (en) 2004-12-07
CN1288465A (zh) 2001-03-21

Similar Documents

Publication Publication Date Title
NO20003730L (no) Triazolo-pyridazinderivater som ligander for GABA reseptorer
NO20032834D0 (no) Benzimidazol- og pyridylimidazol-derivater som ligander for GABA-reseptorer
NO985874D0 (no) Bestemte fosfinylderivater nyttige som naaladase inhibitorer
NO20006071L (no) Isotiazolderivater nyttige som anti-cancer midler
NO20015477D0 (no) 4,5,6,7-tetrahydroindazol-derivater som anti-tumor midler
AU2002232768A1 (en) Benzimidazole and pyridylimidazole derivatives as ligands for GABA receptors
NO980467L (no) 4-mercaptopyrrolidin-derivater som farnesyl-transerase-inhibitorer
DK1456206T3 (da) Azaindolylalkylaminderivater som 5-hydroxytryptamin-6-ligander
AU2002215100A1 (en) Imidazo-pyrimidine derivatives as ligands for gaba receptors
IS5843A (is) Fenýl janþín (yanthine) afleiður
DK1097127T3 (da) Diacylhydrazinderivater som integrininhibitorer
DK0975623T3 (da) Indazolamidforbindelser som sertoninerge midler
DK1455779T3 (da) Indolylalkylaminderivater som 5-hydroxytryptamin-6-ligander
NO20010331L (no) Ftalazinderivater som fosfodiesterase 4-inhibitorer
NO20013684D0 (no) Substituerte fenetylaminderivater
NO974043L (no) Indolderivater som EAA-antagonister
AU4439801A (en) Pyrazolo-triazine derivatives as ligands for gaba receptors
NO20002036D0 (no) Cyklopentenderivater nyttig som antagonister for motilinreseptoren
NO20000822D0 (no) Substituerte 4-okso-3-karboksamider som GABA- hjernereseptorligander
DK1007512T3 (da) Forgrenede alkoxysubstituerede 2-aminopyridiner som NOS-inhibitorer
DK0747346T3 (da) N-acyl-2-arylcyclopropylmethylaminderivater som melatonerge midler
IS6290A (is) Sameinuð pirrolecarboxamíð; GABA viðtakar í heila
NO20006227D0 (no) Tetrahydroquiolinderivater som glycin antagonister
DK1075471T3 (da) Idolylderivater som serotonerge midler
DK1347974T3 (da) Aminotriazolopyridinderivater som adenosinreceptorligander

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees